Guide to public health measures to reduce the impact of influenza pandemics in Europe – ‘The ECDC Menu’
This document presents a menu of possible public measures to be taken during influenza pandemics, giving public health and scientific information on what is known or can be said about their likely effectiveness, costs (direct and indirect), acceptability, public expectations and other more practical considerations. The ‘ECDC Menu’ aims to help EU Member States and institutions, individually or collectively, decide which measures they will apply.
Interim ECDC public health guidance on case and contact management for the new influenza A(H1N1) virus infection
ECDC intends to produce a series of interim guidance documents on suggested procedures to be put in place in order to reduce the risk of transmission of the new influenza A(H1N1) virus. This guidance only applies to a situation when there are relatively few persons under investigation, and will be revised if there seems to be a wider spread.
1st Eastern Partnership Ministerial Conference on Tuberculosis and Multi-Drug Resistance Tuberculosis
High-level meeting to discuss the burden of TB and MDR TB and its elimination as a public health problem in the EU/EEA and Eastern Partnership countries.
Incidence, Severity and Impact of Influenza Meeting
The "Incidence, Severity and Impact of Influenza Meeting" hosted discussions on the assessment of the impact of influenza epidemics, including infection incidence and severity, and the burden of mortality.
Are statins protective in patients with severe respiratory infections? Two new studies from EuropeArchived
In recent years there have been a series of arguments and findings suggesting that Statins (HMG-CoA reductase inhibitors) which used widely to lower cholesterol levels may also be important in reducing the risk associated with severe infective conditions.
Chronological overview of the 2009/2010 H1N1 influenza pandemic and the response of the Centre for Infectious Disease Control (RIVM)Archived
The Centre for Infectious Disease Control (CIb) of the Dutch National Institute for Public Health and the Environment (RIVM) has compiled a chronological overview of that country’s response to the 2009 influenza A(H1N1) pandemic.
Influenza A (H3N2)v Virus in Humans and Swine in the United States – an updateArchived
A report in the US Centers for Disease Control and Prevention (CDC) MMWR this week describes the investigation of mild respiratory illness among swine and people at a county fair in Indiana, USA between 8 and 14 July 2012. This is an important report as it is very clearly documents simultaneous detection of H3N2v influenza viruses in humans and swine in close contact.
Epidemiological update A(H7N9) influenza, 6 February 2014
In March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) influenza virus in patients in eastern China. Since then, human cases have continued to be reported, and as of 7 February 2014 (Figure 1), there have been 308 laboratory-confirmed cases: Zhejiang (122), Guangdong (54), Shanghai (42), Jiangsu (36), Fujian (19), Hunan (7), Jiangxi (5), Henan (4), Anhui (4) ,Beijing (3), Shandong (2), Hebei (1), Guangxi (2), Guizhou (1), Hong Kong (4) and Taiwan (2). In addition, the virus has been detected in one asymptomatic case in Beijing.